The Surprising New Trend in Emerging Markets

In 2000, Pfizer launched Viagra in China. Six months later, 90% of the blue pills sold in Shanghai were counterfeit. Blatant violation of intellectual property law allowed cheap knock-offs and fakes to flood China’s growing drug market. Despite pleas from multinational drug companies, state officials looked the other way. But today, the…